Rubicon Research Pharmaceuticals

Rubicon Research is an Indian pharmaceutical company specializing in contract research, formulation development, and contract manufacturing. Founded in 1999, it operates globally with facilities in India, Canada, and the United States. In 2019, General Atlantic, a U.S.-based growth equity firm, invested USD 100 million in Rubicon Research, acquiring a significant shareholding in the company. This investment has enabled Rubicon Research to expand its global development network and enhance its capabilities in the pharmaceutical industry.